Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conbercept for Macular Edema Secondary to RVO (FALCON)
NCT01809236Phase 2Unknown
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Start
- May 2012
- Primary completion
- Nov 2013
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of conbercept in macular edema, sponsored by Chengdu Kanghong Pharmaceutical Group Co., Ltd.. Status: unknown.
02
Drugs
conbercept
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT01809236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01809236.